Nona Biosciences
Jianing Li, Ph.D., currently serves as the Associate Director of Business Development at Nona Biosciences, focusing on therapeutic antibody discovery and development since January 2025. Previously, Jianing held various leadership roles at Biocytogen, including Regional Director of Business Development for South California and Canada, and achieved significant revenue growth through strategic partnerships across European and North American markets. Jianing's academic experience includes managing pediatric research operations at Emory University, alongside postdoctoral research on chronic cholestatic liver diseases. Jianing earned a Ph.D. in Nutritional Sciences and Pharmacology from the University of Kentucky and possesses advanced degrees in Food Science and Technology from Jiangnan University.
This person is not in the org chart
This person is not in any teams
Nona Biosciences
Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal immunization, single B cell screening, to antibody lead generation and engineering, developability assessment and pharmacological evaluation, leveraging the advantages of Harbour Mice® platforms and the experienced therapeutic antibody discovery team. Harbour Mice® generates fully human monoclonal antibodies in two heavy and two light chains (H2L2) format, as well as heavy chain only (HCAb) format. Integrating Harbour Mice® and a single B cell cloning platform, Nona Biosciences is focused on driving global inventions of transformative next-generation drugs by diversified partnership strategies including co-discovery, platform and antibody discovery, and platform license. The values of the antibody discovery platforms and flexible partnership models have been well validated by more than 50 industry and academic partners within over 200 projects.